Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-002614
Filing Date
2025-04-03
Accepted
2025-04-03 17:26:39
Documents
90
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2648831
2 ex31-1.htm EX-31.1 20109
3 ex31-2.htm EX-31.2 19594
4 ex32.htm EX-32 11115
5 audit_01.jpg GRAPHIC 25878
6 audit_02.jpg GRAPHIC 9044
  Complete submission text file 0001641172-25-002614.txt   11469563

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bixt-20241231.xsd EX-101.SCH 70453
8 XBRL CALCULATION FILE bixt-20241231_cal.xml EX-101.CAL 60521
9 XBRL DEFINITION FILE bixt-20241231_def.xml EX-101.DEF 305599
10 XBRL LABEL FILE bixt-20241231_lab.xml EX-101.LAB 528130
11 XBRL PRESENTATION FILE bixt-20241231_pre.xml EX-101.PRE 453192
92 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2260968
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 25810825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)